Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,800.00
+210.00 (8.11%)
At close: Jun 30, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 53.86 billion as of June 30, 2026. Its market cap has decreased by -29.65% in one year.
Market Cap
53.86B
Enterprise Value
52.81B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,800.00
Market Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 53.86B, a decrease of -78.85%. That is a compound annual growth rate of -22.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 53.86B | -27.84% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 65.28B |
| Naturalendo Tech | 61.73B |
| ADBiotech | 60.10B |
| IMGT Co.,Ltd. | 58.29B |
| EyeGene | 56.89B |
| TegoScience | 55.33B |
| Aptamer Sciences | 47.61B |
| Progen | 47.51B |